BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12530069)

  • 1. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.
    Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Yoshida H; Matsuno T; Saito M; Sato M
    Immunopharmacology; 2000 Sep; 49(3):363-76. PubMed ID: 10996034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
    Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
    J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus.
    Okamoto M; Ohe G; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Ahmed SU; Yoshida H; Moriya Y; Saito M; Sato M
    Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
    Sato M; Kaji R; Urata M; Yoshida H; Yanagawa T; Miyamoto K; Azuma M; Furumoto N; Saito M
    J Biol Response Mod; 1988 Apr; 7(2):212-28. PubMed ID: 3361352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
    Kaji R; Yoshida H; Yanagawa T; Sato M
    J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
    Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
    J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent.
    Oshikawa T; Okamoto M; Tano T; Uddin Ahmed S; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2006 May; 6(5):764-73. PubMed ID: 16546707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice.
    Okamoto M; Oshikawa T; Ohe G; Nishikawa H; Furuichi S; Tano T; Moriya Y; Saito M; Sato M
    Int Immunopharmacol; 2001 Sep; 1(9-10):1789-95. PubMed ID: 11562070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
    J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity.
    Maheshwari A; Han S; Mahato RI; Kim SW
    Gene Ther; 2002 Aug; 9(16):1075-84. PubMed ID: 12140735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; AntĂșnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.
    Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA
    J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cytokine-inducing activity in a lipoteichoic acid-related molecule isolated from a penicillin-killed group A Streptococcus and from untreated bacteria.
    Okamoto M; Oshikawa T; Ohe G; Furuichi S; Nishikawa H; Tano T; Bando T; Yoshida H; Matsubara S; Matsuno T; Saito M; Sato M
    Int Immunopharmacol; 2001 Oct; 1(11):1957-68. PubMed ID: 11606027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
    Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
    J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
    Habu S; Fukui H; Shimamura K; Kasai M; Nagai Y; Okumura K; Tamaoki N
    J Immunol; 1981 Jul; 127(1):34-8. PubMed ID: 7240748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.